News

Home News

04

Apr2022

PMPRB 2020 Annual Report Shows Almost 30% Decrease in New Patented Medicines Reported Since 2018

/ PMPRB, What's New
On March 31, 2022, PMPRB published its 2020 Annual Report on its website. Key statistics reinforce concerns about ... Read More

25

Mar2022

Supreme Court Dismisses Attorney General’s Application for Leave to Appeal FCA decision in PMPRB Alexion Soliris Matter

/ News, PMPRB, What's New
On September 29, 2021, the Attorney General of Canada applied for leave to appeal to the Supreme Court ... Read More

22

Feb2022

Quebec Court Strikes 2 of 3 PMPRB Changes

/ PMPRB, What's New
On February 18, 2022, the Quebec Court of Appeal ruled that two of the three major proposed changes ... Read More

14

Feb2022

Reminder: Form 3 filing is due to the PMPRB On March 1, 2022

/ News, PMPRB, What's New
This is a reminder to patentees of their filing requirements respecting revenues and development expenditures. These filing requirements ... Read More

31

Jan2022

Updates to the Ontario Guidelines for Drug Submission and Evaluation

/ Ontario, What's New
The Ontario Ministry of Health has recently updated the Ontario Guidelines for Drug Submission and Evaluation (Guidelines). In ... Read More

17

Dec2021

PMPRB Proposed Amendments to the July 1, 2021 Guidelines

/ PMPRB, What's New
On October 28th, 2021, PMPRB provided their first update to the Notice & Comment that was issued on ... Read More

17

Dec2021

Consultation Notice: Proposed Framework for a Potential Pan-Canadian Formulary

/ Canada, National Pharmacare, News, What's New
Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022.  A discussion paper ... Read More

17

Dec2021

CADTH Pharmaceutical Reviews Update- Issue 27

/ CADTH, News, What's New
On December 16, 2021, CADTH provided an update regarding CADTH’s drug review programs. A. ... Read More